[Clinical studies of fortimicin in surgical infections].
A new aminoglycoside antibiotic, fortimicin, was administered intramuscularly to 3 patients (panperitonitis). Clinical response was excellent in 2 cases and good in 1 case. The effective rate was 100%. In these patients, fortimicin was given in a dose of 600 mg, 2 or 3 times daily for 6 to 7 days. No adverse effect was observed. Therefore fortimicin was suggested to be a useful drug for the treatment of panperitonitis.
D000368:Aged; D000617:Aminoglycosides / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001419:Bacteria / Q000187:drug effects; D004341:Drug Evaluation; D004352:Drug Resistance, Microbial; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010538:Peritonitis / Q000188:drug therapy* / Q000382:microbiology; D011183:Postoperative Complications / Q000188:drug therapy
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; C023521:fortimicins